Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Yuezhikangtai Biomedicines discloses AXL and/or c-Met inhibitors

May 15, 2019

Hitgen patents histone deacetylase inhibitors

May 15, 2019

New vasopressin V1A and V2 receptor antagonists described by Bayer

May 15, 2019

Advent Pharma discovers fibroblast growth factor receptor 4 inhibitors

May 15, 2019

Angex Pharmaceutical identifies indoleamine 2,3-dioxygenase 1 inhibitors

May 15, 2019

Tolimidone leads to significant reduction of HbA1c in phase IIb trial in type 2 diabetes

May 15, 2019

Protagonist Therapeutics presents phase I data for PN-943

May 15, 2019

AMS-0421, an aptamer targeting VEGF-A for retinal disease

May 15, 2019

Batavia Biosciences and University of Tokyo to develop a vector-based vaccine against Nipah virus

May 15, 2019

Inebilizumab demonstrates safety and efficacy in phase III N-MOmentum study

May 15, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...